All Type of News
Congresswoman In-Soon Nam-Yun claiming “The low margins of multinational pharmaceutical companies with 5-6.75% need to be revised”
The low margins of multinational pharmaceutical companies became an issue.
At the Q&A session of the national inspection about Ministry of Health and Welfare on the 13th, Congresswoman In-Soon Nam-Yun (Health and Wel...
Pushing forward with the abolition of pharmaceutical wholesalers’ equity base
It seems that the equity base of pharmaceutical wholesalers, which is currently set to KRW 500 million, is going to be abolished.
Ministry of Health and Welfare made a pre-announcement for ‘partially revised enforcem...
Korea Pharmaceutical Distribution Association said “Switching goals from blocking the decrease of margins to requesting the raise”
The distribution industry, concentrating on preventing from lowering its distribution cost so far, will have movements to increase the distribution cost.
One of the directors in Korea Pharmaceutical Distribution Asso...
‘Attention’ on IPOs of pharmaceutical companies’ branches in succession
Branches of pharmaceutical companies have drawn people’s attention with filing initial public offerings (IPO).
According to the industry concerned on the 13th, Green Cross MS, a branch of Green Cross, Humedix, a bran...
An endless patent war for dementia patches… who will be the winner between Novartis and SK?The industry has been paying attention on a result of patent litigation for dementia patches between Novartis and SK Chemicals.
The conflict has proceeded since the late 2012 b...
|
.jpg)
The beginning of the Hanmi’s first generic development for a gout medicine ‘Feburic’Hanmi Pharmaceutical started on generic development of a gout medicine ‘Feburic (Febuxostat)’ as the very first domestic pharmaceutical company in Korea.
According to Ministry ...
|
.jpg)
Multinational pharmaceutical companies are considering increasing distribution costs due to the aggressiveness of wholesales
Due to the aggressiveness of the pharmaceutical distribution industry, it is reported that multinational pharmaceutical companies actively consider raising the distribution costs.
The report has drawn attention on th...
Ministry of Health and Welfare concerns between patients’ safety and privacy
While the privacy protection act stating ‘Prohibition on collecting resident registration numbers to schedule doctor’s appointments’ has been delayed until February 2015, Ministry of Health and Welfare has got in deep...
The current fascination of the Korean pharmaceutical market from the outside point of view
There are a great number of domestic pharmaceutical companies seeking to advance in foreign markets due to its sales limit in the Korean pharmaceutical market.
Then, the question is how multinational pharmaceutical c...
Exclusive rights for generic medicines will last 14 months at most starting the accepted date
It seems that insured generic medicines, which receive exclusive sale rights based on Patent Linkage System (hereinafter referring to PLS), will achieve a maximum 14-month period from the accepted date.
Moreover, inf...
